Adverse renal effects of NLRP3 inflammasome inhibition by MCC950 in an interventional model of diabetic kidney disease

Activation of nucleotide-binding oligomerization domain-like receptor pyrin domain containing 3 (NLRP3) inflammasome has been reported in diabetic complications including diabetic kidney disease (DKD). However, it remains unknown if NLRP3 inhibition is renoprotective in a clinically relevant interve...

Descripción completa

Detalles Bibliográficos
Autores principales: Østergaard, Jakob A., Jha, Jay C., Sharma, Arpeeta, Dai, Aozhi, Choi, Judy S.Y., de Haan, Judy B., Cooper, Mark E., Jandeleit-Dahm, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Diabetes & Metabolic Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777085/
https://www.ncbi.nlm.nih.gov/pubmed/35048962
http://dx.doi.org/10.1042/CS20210865

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777085/
https://www.ncbi.nlm.nih.gov/pubmed/35048962
http://dx.doi.org/10.1042/CS20210865

Ejemplares similares